Canadian Islet Research and Training Network - Réseau de Recherche et Formation sur les Ilots du Canada (CIRTN-R2FIC)

糖尿病是加拿大增长最快的流行病之一，超过10%的人口被诊断患有这种疾病，另外20-30%的人患有糖尿病前期。越来越需要培训这一领域的专家和科学家，推动创新，并为政府管理糖尿病造成的日益严重的健康和经济负担提供支持。100年前在多伦多发现的胰岛素是控制血糖的主要决定因素。加拿大胰岛研究和培训网络-加拿大胰岛研究和培训网络（CIRTN-R2 FIC）成立于2020年，旨在增加研究交流和培训的机会，重点关注胰岛素和胰岛的生物学（www.islets.ca）。CIRTN-R2 FIC汇集了5个省11个机构的45个胰岛生物学实验室。有了NSERC-CREATE的资助，我们将为CIRTN-R2 FIC学员提供参加一个独特的、以胰岛和糖尿病为重点的全国性培训计划的机会，以更好地为竞争激烈的多样化就业市场做好准备。该计划包括：加强指导;学术和技术培训;行业或学术实习和国际交流;关于宣传、政策、监管事务、沟通和业务发展等主题的讲习班;会议和网络;以及公平多样性和包容性培训。CIRTN-R2 FIC CREATE学员将受到开发肥胖和糖尿病治疗方法、生物标志物发现以及医疗设备和生物传感器的公司的高度追捧，推动加拿大学术和工业部门的增长，并加强这些领域的创新。

Diabetes is one of the fastest growing epidemic diseases in Canada, with over 10% of the population diagnosed with this disease and another 20-30% living with pre-diabetes. There is a growing need to train experts and scientists in this area, to fuel innovation and provide support to the government in managing the rising health and economic burden caused by diabetes. Insulin, discovered 100 years ago in Toronto, is a major determinant of blood sugar control. This hormone is produced by specialized cells within the pancreas called the islets of Langerhans.The Canadian Islet Research and Training Network - Réseau de Recherche et Formation sur les Ilots du Canada (CIRTN-R2FIC) was formed in 2020 to grow opportunities for research exchange and training focused on the biology of insulin and the pancreatic islets of Langerhans (www.islets.ca). CIRTN-R2FIC brings together 45 islet-biology-focused laboratories at 11 institutions in 5 provinces. With this NSERC-CREATE grant we will provide CIRTN-R2FIC trainees with the opportunity to participate in a unique, islet- and diabetes-focused country-wide training program to better prepare them for a competitive and diverse job market.The program includes: enhanced mentorship; scholastic and technical training; industry or academic internship and international exchange; workshops on topics including advocacy, policy, regulatory affairs, communication, and business development; meeting and networking; and equity diversity and inclusion training. CIRTN-R2FIC CREATE trainees will be highly sought after by companies developing treatments for obesity and diabetes, biomarker discovery, and medical devices and biosensors, fuelling growth in both academic and industrial sectors across Canada and strengthening innovation in these areas.